# Boston Scientific Corporation (BSX) — Q4-2021 Earnings Results

**Report date:** 2022-02-02 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q4-2021

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Down 4.74%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.45 | N/A | +3.21% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Neutral

Management acknowledged the impact of external factors on performance. They remain focused on long-term growth strategies.

**Key quotes:**

> Management highlighted ongoing challenges in the supply chain.

> They emphasized a commitment to innovation despite market pressures.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Boston Scientific's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock dropped 4.74%, likely reflecting investor concerns about ongoing supply chain challenges and the lack of revenue data. The absence of guidance may also have contributed to the negative market reaction.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q4-2021_